Citation only
via Europe PMC
Bioactive vitamin E-NAD<sup>+</sup> conjugate nanoparticles for osteoarthritis management via simultaneous suppression of inflammation and oxidative stress.
Zhai W, Mao X, Tian A, Jia J, Miao Z, Liu A, Zhao N, Wang Z, Zhao X, Li X, Ma X, Zhao Y.
Biomaterials · 2027
Abstract
The involvement of oxidative stress, inflammation, and energy metabolism disorders in osteoarthritis (OA) makes it challenging to handle these problems using a single therapeutic agent concurrently. Here, we report a tailored bioactive conjugate consisting of a hydrophobic radical-trapping antioxidant (vitamin E, VE), a hydrophilic nicotinamide adenine dinucleotide (NAD<sup>+</sup>), and a reactive oxygen species (ROS)-responsive phenylboronic acid linker. The conjugate self-assembly produced VE-NAD<sup>+</sup> nanoparticles with high drug loading (>90%), a small hydrodynamic size (ca. 60 nm), and good kinetic stability. The nanoparticles significantly increased intracellular NAD<sup>+</sup> levels, inhibited lipid peroxidation and oxidative stress, and suppressed pro-inflammatory cytokine release in macrophages (RAW 264.7) and rat chondrocytes in vitro. The multifunctional nanoparticles also down-regulated the key matrix metalloproteinases. Upon intra-articular delivery, the VE-NAD<sup>+</sup> nanoparticles potently mitigated synovial inflammation and alleviated cartilage damage in a spontaneous OA mouse model, as evidenced by magnetic resonance imaging, histological staining, critical biomarker quantification, and OA grading assessment. This work provides an innovative disease-modifying approach to OA management, which may have applications in other aging-related disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.biomaterials.2026.124606
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
W, Z., X, M., A, T., J, J., Z, M., A, L., N, Z., Z, W., X, Z., X, L., X, M., & Y., Z. (2027). Bioactive vitamin E-NAD<sup>+</sup> conjugate nanoparticles for osteoarthritis management via simultaneous suppression of inflammation and oxidative stress. <em>Biomaterials</em>. https://doi.org/10.1016/j.biomaterials.2026.124606
Vancouver
W Z, X M, A T, J J, Z M, A L, et al. Bioactive vitamin E-NAD<sup>+</sup> conjugate nanoparticles for osteoarthritis management via simultaneous suppression of inflammation and oxidative stress. Biomaterials. 2027. doi:10.1016/j.biomaterials.2026.124606.
BibTeX
@article{zhai2027Bioact,
title = {Bioactive vitamin E-NAD<sup>+</sup> conjugate nanoparticles for osteoarthritis management via simultaneous suppression of inflammation and oxidative stress.},
author = {Zhai W and Mao X and Tian A and Jia J and Miao Z and Liu A and Zhao N and Wang Z and Zhao X and Li X and Ma X and Zhao Y.},
journal = {Biomaterials},
year = {2027},
doi = {10.1016/j.biomaterials.2026.124606},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2016
Open access · CC-BY
Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis
Brain Communications 2023
Open access · CC-BY
Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants
Elsevier eBooks 2023
Citation only
Reactive oxygen species and oxidative stress
Elsevier eBooks 2011
Citation only
Reactive Oxygen Species and Oxidative Stress
Oxidative Medicine and Cellular Longevity 2021
Open access · CC-BY
Data‐Driven Cluster Analysis of Oxidative Stress Indexes in relation to Vitamin D Level, Age, and Metabolic Control in Patients with Type 2 Diabetes on Metformin Therapy
Osteoarthritis and Cartilage 2005
Open access · OA